Lifemd (LFMD) closed at $1.85 on November 16, 2026, down 15.7% from the previous close, on volume of 1,347,342 shares (30-day average 1,013,865).
Data as of November 16, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 16, 2026. See the largest for 5, 30, 60 and 90 days
LifeMD Earnings Call Highlights Growth Despite 2026 Reset
TipRanks (Sun, 15-Nov 7:11 PM ET)
LifeMD GAAP EPS of -$0.11 beats by $0.03, revenue of $44.6M misses by $4.25M
Seeking Alpha News (Thu, 12-Nov 11:54 PM ET)
LifeMD Reports Third-Quarter Results and Subscriber Growth
TipRanks (Thu, 12-Nov 4:43 PM ET)
LifeMD Reports Third Quarter 2026 Results
Globe Newswire (Thu, 12-Nov 4:05 PM ET)
Business Wire (Tue, 10-Nov 11:00 AM ET)
Business Wire (Tue, 10-Nov 9:00 AM ET)
Business Wire (Mon, 9-Nov 2:55 PM ET)
LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
Globe Newswire (Fri, 6-Nov 7:25 PM ET)
Globe Newswire (Thu, 5-Nov 7:30 AM ET)
LifeMD to Report Third Quarter 2026 Financial Results on November 9
Globe Newswire (Tue, 20-Oct 4:05 PM ET)
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Lifemd trades on the NASDAQ stock market under the symbol LFMD.
As of November 17, 2026, LFMD stock price declined to $1.80 with 703,504 million shares trading.
LFMD has a beta of 0.86, meaning it tends to be less sensitive to market movements. LFMD has a correlation of 0.03 to the broad based SPY ETF.
LFMD has a market cap of $87.00 million. This is considered a Micro Cap stock.
Last quarter Lifemd reported $45 million in Revenue and -$.11 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.08.
In the last 3 years, LFMD traded as high as $15.84 and as low as $1.60.
The top ETF exchange traded funds that LFMD belongs to (by Net Assets): VTI, IWM, VXF, KOMP, VTWO.
LFMD has underperformed the market in the last year with a price return of -61.1% while the SPY ETF gained +10.1%. LFMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -47.8% and -22.1%, respectively, while the SPY returned -5.5% and -2.7%, respectively.
LFMD support price is $1.73 and resistance is $1.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMD shares will trade within this expected range on the day.